Want to see PRLD full AI Analyst Report?
Prelude Therapeutics (PRLD) Q2 2026 Earnings Report
PRLD Q2 2026 EPS Results
- Actual EPS
- -$0.14
- Consensus EPS
- -$0.20
- Beat/Miss
- Beat by +$0.06
- One Year Ago EPS
- -$0.41
PRLD Q2 2026 Revenue Results
- Actual Revenue
- $5.70M
- Expected Revenue
- $0
- Beat/Miss
- Beat by +$5.70M
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/19/2026
- Time
- TBA
- Conference Call
- Wednesday, August 19, 2026
PRLD Upcoming Earnings
Prelude Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
PRLD Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 05, 2026 | 2026 (Q3) | 0.01- | -0.26 | ― | ― |
| Aug 19, 2026 | 2026 (Q2) | -0.20-0.14 | -0.41 | 65.85% (+0.27) | |
| May 12, 2026 | 2026 (Q1) | -0.25-0.13 | -0.42 | 69.05% (+0.29) | |
| Mar 10, 2026 | 2025 (Q4) | -0.03-0.20 | -0.37 | 45.95% (+0.17) | |
| Nov 12, 2025 | 2025 (Q3) | -0.37-0.26 | -0.43 | 39.53% (+0.17) | |
| Aug 14, 2025 | 2025 (Q2) | -0.44-0.41 | -0.46 | 10.87% (+0.05) | |
| May 06, 2025 | 2025 (Q1) | -0.47-0.42 | -0.42 | 0.00% (+0.00) | |
| Mar 10, 2025 | 2024 (Q4) | -0.46-0.37 | -0.45 | 17.78% (+0.08) | |
| Nov 06, 2024 | 2024 (Q3) | -0.47-0.43 | -0.45 | 4.44% (+0.02) | |
| Aug 12, 2024 | 2024 (Q2) | -0.43-0.46 | -0.54 | 14.81% (+0.08) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
